Ahrén C M, Svennerholm A M
Infect Immun. 1985 Oct;50(1):255-61. doi: 10.1128/iai.50.1.255-261.1985.
The diarrheal response to an initial and a second infection with Escherichia coli expressing various enterotoxins (the heat-stable toxin [ST] alone or in combination with the heat-labile toxin [LT]) and colonization factor antigens (CFA/I, CFA/II, or E8775-type) was studied in the reversible tie adult rabbit diarrhea model. An initial infection with high doses (1 X 10(10) to 5 X 10(11) bacteria) of the various strains regularly induced diarrhea which was usually self-limiting (only 7 of 85 animals died). The diarrheal response to equally effective doses of different strains producing both ST and LT (ST/LT) did not differ significantly with serotype or colonization factor antigen. ST/LT-producing strains appeared to induce severe disease more regularly than ST-producing strains carrying the same adhesin. Previous infection with CFA/I-carrying, ST/LT-producing E. coli protected all animals reinfected with an otherwise highly diarrheogenic dose of the same strain as well as against challenge with a CFA/I-carrying, ST/LT-producing strain with different O-, K-, and H-antigens. Fecal excretion of bacteria was also significantly reduced in the protected animals, although not completely eliminated. When only one of the two antigens, CFA/I and LT, was shared by the immunizing and rechallenge strains, partial protection was evident consistent with independent antibacterial (anti-CFA) and antitoxic (anti-LT) immune mechanisms. Oral immunization with purified CFA/I significantly reduced fluid secretion in intestinal loops infected with CFA/I-carrying enterotoxigenic bacteria.
在成年兔可逆性结扎腹泻模型中,研究了对表达各种肠毒素(单独的热稳定毒素[ST]或与热不稳定毒素[LT]联合)和定居因子抗原(CFA/I、CFA/II或E8775型)的大肠杆菌初次感染和再次感染的腹泻反应。用高剂量(1×10¹⁰至5×10¹¹个细菌)的各种菌株进行初次感染通常会诱发腹泻,且腹泻通常为自限性(85只动物中仅7只死亡)。对产生ST和LT(ST/LT)的不同菌株同等有效剂量的腹泻反应,在血清型或定居因子抗原方面无显著差异。产生ST/LT的菌株似乎比携带相同黏附素的产ST菌株更常诱发严重疾病。先前感染携带CFA/I的产ST/LT大肠杆菌,可保护所有再次感染相同菌株高剂量(否则会引起高度腹泻)的动物,以及抵抗携带CFA/I、产ST/LT且具有不同O、K和H抗原的菌株的攻击。在受保护的动物中,细菌的粪便排泄也显著减少,尽管未完全消除。当免疫和再次攻击菌株仅共享CFA/I和LT这两种抗原中的一种时,部分保护作用明显,这与独立的抗菌(抗CFA)和抗毒(抗LT)免疫机制一致。用纯化的CFA/I进行口服免疫可显著减少感染携带CFA/I的产肠毒素细菌的肠袢中的液体分泌。